Clinical Significance of Fibromyalgia Syndrome in Rheumatoid Arthritis: Prevalence and Associated Factors in Subsaharan Africa
DOI:
https://doi.org/10.12970/2310-9874.2020.08.01Keywords:
Fibromyalgia, rheumatoid arthritis, black, Africa.Abstract
Objective: The aim of this work was to study the prevalence and factors associated with fibromyalgia in African Black rheumatoid arthritis patients in the south of the Sahara.
Method: It was a cross-sectional case-control study conducted from January 2017 to June 2017. Seventy-five rheumatoid arthritis patients (case) and 150 healthy subjects without rheumatoid arthritis (controls) were consecutively recruited during the rheumatology consultation period were include.
Result: The mean duration of rheumatoid arthritis was 3.75 years ± 3.60. The mean Disease Activity Score (DAS)28 was 5.68 ± 0.91. Forty-eight rheumatoid arthritis patients (64.0%) and 20 controls (13.3%) respectively had fibromyalgia. The difference was statistically significant (p <0.0001). Among the risk factors for fibromyalgia that were studied, only the absence of rheumatoid factors was associated with the presence of fibromyalgia.
Conclusion: The prevalence of fibromyalgia was significantly higher during rheumatoid arthritis than in a healthy control.
References
Lee J-W, Lee K-E, Park D-J, Kim S-H, Nah S-S, Lee JH, Kim S-K, Lee Y-A, Hong S-J, Kim H-S, Lee H-S, Kim HA, Joung C-I, Kim S-H, Lee S-S. Determinants of quality of life in patients with fibromyalgia: A structural equation modeling approach. PLoS One 2017; 12(2): e0171186. https://doi.org/10.1371/journal.pone.0171186
Bannwarth B, Blotman F, Roué-Le Lay K, Caubère JP, André E, Taïeb C. Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine 2009; 76(2): 184-7. https://doi.org/10.1016/j.jbspin.2008.06.002
Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caubère JP, Le Lay K, Taieb C, Matucci-Cerinic M. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 2010; 39(6): 448-53. https://doi.org/10.1016/j.semarthrit.2008.12.003
Guermazi M, Ghroubi S, Sellami M, Elleuch M, Feki H, André E, Schmitt C, Taieb C, Daak J, Baklouti S, Elleuch MH. Fibromyalgia prevalence in Tunisia. Tunis Med 2008; 86(9): 806-11.
Coury F, Rossat A, Tebib A, Letroublon MC, Gagnard A, Fantino B, et al. Rheumatoid arthritis and fibromyalgia: a frequent unrelated association complicating disease management. J Rheumatol 2009; 36: 58-62. https://doi.org/10.3899/jrheum.080366
Ranzolin A, Brenol JC, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, Xavier RM. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum 2009; 61(6): 794-800. https://doi.org/10.1002/art.24430
Perrot S, Peixoto M, Dieudé P, Hachulla E, Avouac J, Ottaviani S, Allanore Y. Patient phenotypes in fibromyalgia comorbid with systemic sclerosis or rheumatoid arthritis: influence of diagnostic and screening tests. Screening with the FiRST questionnaire, diagnosis with the ACR1990 and revised ACR 2010 criteria. Clin Exp Rheumatol 2017; 35 Suppl 105(3): 35-42.
El-Rabbat MS, Mahmoud NK, Gheita TA. Clinical significance of fibromyalgiasyndrome in different rheumatic diseases: Relation to disease activity and quality of life. Reumatol Clin 2018; 14(5): 285-9. https://doi.org/10.1016/j.reuma.2017.02.008
Fazaa A, Bouden S, Abdelghani K, Kassab S, Chekili S, Laatar A. Prévalence dela fibromyalgie dans la polyarthrite rhumatoïde. [Abstract PE.Di-066] Rev Rhum 2016; 83(suppl1): A199. https://doi.org/10.1016/S1169-8330(16)30489-6
Aletaha D, Neogi T, Silman AJ, et al. rheumatoid arthritis classificationcriteria: an American College of Rheumatology/European league against Rheumatism collaborative initiative. Ann Rheum Dis 2010; 69: 1580-8. https://doi.org/10.1136/ard.2010.138461
Perrot S, Bouhassira D, Fermanian J. Cercle d'Etude de la Douleur en Rhumatologie. Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain 2010; 150(2): 250-6. https://doi.org/10.1016/j.pain.2010.03.034
Fan A, Tournadre A, Pereira B, Tatar Z, Couderc M, Malochet-Guinamand S, Mathieu S, Soubrier M, Dubost JJ. Performance of Fibromyalgia Rapid Screening Tool (FiRST) to detect fibromyalgia syndrome in rheumatic diseases. Rheumatology (Oxford) 2016; 55(10): 1746-50. https://doi.org/10.1093/rheumatology/kew244
Dhir V, Aggarwal A, Misra R, Lawrence A. The prevalence and impact of fibromyalgia in rheumatoid arthritis. [Abstract 031]. Indian Journal of rheumatology 2008; 3: S24. https://doi.org/10.1016/S0973-3698(10)60405-0
Fan A, Pereira B, Tournadre A, Tatar Z, Malochet-Guinamand S, Mathieu S, Couderc M, Soubrier M, Dubost JJ. Frequency of concomitant fibromyalgia in rheumatic diseases: Monocentric study of 691 patients. Semin Arthritis Rheum 2017; pii: S0049-0172(16)30369-9. https://doi.org/10.1016/j.semarthrit.2017.01.005
Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO. Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia. Int J Rheum Dis 2018; 21(3): 639-46. https://doi.org/10.1111/1756-185X.13055
Kim H, Cui J, Frits M, Iannaccone C, Coblyn J, Shadick NA, Weinblatt ME, Lee YC. Fibromyalgia Predicts Two-Year Changes in Functional Status in Rheumatoid Arthritis Patients. Arthritis Care Res (Hoboken) 2017; 69(12): 1871-1877. https://doi.org/10.1002/acr.23216
Zammurrad S, Munir W, Farooqi A. Disease activity score in rheumatoid arthritis with or without secondary fibromyalgia. J Coll Physicians Surg Pak 2013; 23(6): 413-7.
Haliloglu S, Carlioglu A, Akdeniz D, Karaaslan Y, Kosar A. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int 2014; 34(9): 1275-80. https://doi.org/10.1007/s00296-014-2972-8
Zabsonré Tiendrébéogo WJS, Kaboré F, Nanema D, Savadogo B, Dravé, Sougué C, Soupougdou C, Ouédraogo M, Ouédraogo DD. Frequency and Factors Associated with Depression in Rheumatoid Arthritis in African Black Patients: Case-Control Study. Open Journal of Rheumatology and Autoimmune Diseases 2019; 9: 35-41. https://doi.org/10.4236/ojra.2019.92004
Challa DNV. Crowson CS. Davis JM III. The Patient Global Assessment of Disease Activity in Rheumatoid Arthritis: Identification of Underlying Latent Factors. Rheumatol Ther 2017; 4: 201-8. https://doi.org/10.1007/s40744-017-0063-5
Lee YC, Bingham CO 3rd, Edwards RR, Marder W, Kristine P, Bolster MB, Clauw DJ, Moreland LW, Lu B, Wohlfahrt A, Zhang Z, Neogi T. Pain Sensitization is Associated with Disease Activity in Rheumatoid Arthritis Patients: A Cross-Sectional Study. Arthritis Care Res (Hoboken) 2017; 69(12): 1871-7.
Mian AN, Chaabo K, Wajed J, Subesinghe S, Gullick NJ, Kirkham B, Garrood T. Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound. BMC Musculoskelet Disord 2016; 17(1): 404. https://doi.org/10.1186/s12891-016-1258-6
